2013-07-01
Productivity costs in economic evaluations: past, present, future
Publication
Publication
PharmacoEconomics , Volume 31 - Issue 7 p. 537- 549
Abstract
Productivity costs occur when the productivity
of individuals is affected by illness, treatment, disability or
premature death. The objective of this paper was to review
past and current developments related to the inclusion,
identification, measurement and valuation of productivity
costs in economic evaluations. The main debates in the
theory and practice of economic evaluations of health
technologies described in this review have centred on the
questions of whether and how to include productivity costs,
especially productivity costs related to paid work. The past
few decades have seen important progress in this area.
There are important sources of productivity costs other
than absenteeism (e.g. presenteeism and multiplier effects
in co-workers), but their exact influence on costs remains
unclear. Different measurement instruments have been
developed over the years, but which instrument provides
the most accurate estimates has not been established.
Several valuation approaches have been proposed. While
empirical research suggests that productivity costs are best
included in the cost side of the cost-effectiveness ratio, the
jury is still out regarding whether the human capital
approach or the friction cost approach is the most appropriate
valuation method to do so. Despite the progress and
the substantial amount of scientific research, a consensus
has not been reached on either the inclusion of productivity
costs in economic evaluations or the methods used to
produce productivity cost estimates. Such a lack of consensus
has likely contributed to ignoring productivity costs
in actual economic evaluations and is reflected in variations
in national health economic guidelines. Further research is
needed to lessen the controversy regarding the estimation
of health-related productivity costs. More standardization
would increase the comparability and credibility of economic
evaluations taking a societal perspective.
Key Points for Decision Makers
• Despite their strong impact on cost-effectiveness
outcomes, productivity costs are ignored in the
majority of economic evaluations
• Productivity costs related to unpaid labour have
received relatively little attention in the scientific
literature
• Common standards regarding the inclusion, identification,
measurement and valuation of productivity
costs are lacking
Additional Metadata | |
---|---|
doi.org/10.1007/s40273-013-0056-3, hdl.handle.net/1765/50591 | |
PharmacoEconomics | |
Organisation | Erasmus School of Health Policy & Management (ESHPM) |
Krol, M., Brouwer, W., & Rutten, F. (2013). Productivity costs in economic evaluations: past, present, future. PharmacoEconomics (Vol. 31, pp. 537–549). doi:10.1007/s40273-013-0056-3 |